Copyright
©The Author(s) 2025.
World J Stem Cells. Aug 26, 2025; 17(8): 108898
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.108898
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.108898
Table 3 Neural organoids differentiation protocols
Ref. | Protocol | NOs phases | Plate | Medium | Supplements | Factors | ECM used | Time of each phase |
Van De Looverbosch et al[33] | N/A | 2D hiPSCs neural induction | N/A | Neurobasal + DMEM/F12 + Glutamax | Glutamax, MEM-NEAA, sodium pyruvate, 2-ME, human insulin, N2s, B27s, PS | LDN-193189 and SB-431542 | - | 11 days |
2D NPCs maturation | N/A | Neurobasal + DMEM/F12 + Glutamax | Glutamax, MEM-NEAA, sodium pyruvate, 2-ME, human insulin, N2s, B27s, PS | - | - | 19 days | ||
Organoid production | U-bottom 96-well1 | - | - | - | - | 7 days | ||
Ferreira et al[34] | Unguided | EB formation | ULA U-bottom 96-well | mTeSR 1 | Normocin | ROCKi | - | Not clear |
Neural induction | ULA U-bottom 96-well | DMEM/F12 | Knockout serum replacement, MEM-NEAA, Glutamax, 2-ME | ROCKi and bFGF | - | Until EBs reached 400-600 μm | ||
Neural induction | ULA 24-well | DMEM/F12 | N2s, MEM-NEAA, heparin | - | - | Until neuroepithelium cues appeared | ||
ECM embedding | ULA 6-well | Neurobasal + DMEM/F12 | N2s, B27s without vitamin A, MEM-NEAA, Glutamax, 2-ME, human insulin, Normocin | - | Matrigel | 4 days | ||
Neural differentiation/maturation | ULA 6-well on orbital shaker | Neurobasal + DMEM/F12 | N2s, B27s with vitamin A, MEM-NEAA, Glutamax, 2-ME, human insulin, Normocin | - | - | Up to use in co-cultures (> 40 days) | ||
Pedrosa et al[25] | Guided | EB formation/neural induction | ULA V-shaped 96-well | DMEM/F12 | KnockOut serum, MEM-NEAA, Glutamax, 2-ME, PS | ROCKi, DM and, SB-431542 | - | 7 days |
Neural differentiation | 96-well | Neurobasal-A | B27 supplement without vitamin A, Glutamax, and PS | bFGF and EGF | - | 14 days | ||
Neural differentiation | ULA 6-well | Neurobasal-A | B27s without vitamin A, Glutamax, and PS | bFGF, EGF, BDNF and, NT-3 | - | 21 days | ||
Neural maturation | ULA 6-well | Neurobasal-A | B27s without vitamin A, Glutamax, and PS | - | - | Up to use in co-cultures (> 42 days) | ||
Fedorova et al[35] | Unguided | EB formation | V-bottom 96-well2 | mTeSR 1 | - | ROCKi | - | Until EB were at least 400 μm in diameter |
Neural induction | ULA 24-well | DMEM/F12 | N2s, Glutamax, MEM-NEAA and, heparin | - | - | 6 days | ||
ECM embedding | 6 cm dish | Neurobasal + DMEM/F12 | Glutamax, MEM-NEAA, N2s, human insulin, 2-ME, B27s without vitamin A and, PS | - | Geltrex | 4 days | ||
Neural differentiation/maturation | Spinning bioreactor | Neurobasal + DMEM/F12 | Glutamax, MEM-NEAA, N2s, human insulin, 2-ME, B27s with vitamin A and, PS | - | - | Up to use in co-cultures | ||
Bassot et al[36] | Guided | EB formation | Microwell plate | Serum-free medium | - | ROCKi | - | 12-36 hours |
Neural induction | 6-well on orbital shaker | Neurobasal + DMEM/F12 + Glutamax | B27s and MEM-NEAA | TGFβ/activin/Nodali and BMPi | - | 4 days | ||
Neural differentiation | 6-well on orbital shaker | Neurobasal + DMEM/F12 + Glutamax | - | EGF, bFGF, BMPi, GDNF, BDNF and iγ-secretase | - | 17 days | ||
Neural maturation | PTFE membrane 6-well without agitation | Neurobasal + DMEM/F12 + Glutamax | - | GDNF, BDNF and iγ-secretase | - | Up to use in co-cultures | ||
Goranci-Buzhala et al[37] | Guided | EB formation/neural induction | ULA 96-well | NIM | - | ROCKi | 5 days | |
ECM embedding | NR | Neurobasal + DMEM/F12 | N2s, B27s without vitamin A, 2-ME, human insulin, L-glutamin and, MEM-NEAA | - | Matrigel | 4 days | ||
Neural differentiation/maturation | Spinner flask | Neurobasal + DMEM/F12 | N2s, B27s without vitamin A, 2-ME, human insulin, L-glutamin, MEM-NEAA | DM; SB-431542 | - | Up to use in co-cultures (> 10 days) | ||
Azzarelli et al[14] | Unguided | EB formation | ULA 96-well | EB-media (basal 1 plus supplement A) | - | ROCKi | 5 days | |
Neural induction | ULA 24-well | NIM (basal 1 plus supplement B) | - | - | - | 2 days | ||
ECM embedding | 6 cm dish | Expansion media (basal 2 plus supplement C and D) | - | - | Matrigel | 3 days | ||
Neural differentiation/maturation | 6 cm dishes on orbital shaker | Maturation medium (basal 2 plus supplement E) | Matrigel dissolved in the medium | - | - | Up to use in co-cultures (> 10 days) | ||
Krieger et al[38] | Unguided | EB formation/neural induction | AggreWell | NIM | - | ROCKi | - | 5 days |
ECM embedding | NR | Neurobasal + DMEM/F12 + Glutamax | 1:1 mixture of (N2s, human insulin, L-glutamine, MEM-NEAA, 2-ME): B27s, L-glutamine and, PS | - | Matrigel | Not clear | ||
Neural differentiation/maturation | NR | Neurobasal + DMEM/F12 + Glutamax | 1:1 mixture of (N2s, human insulin, L-glutamine, MEM-NEAA, 2-ME): B27s, L-glutamine and, PS | - | - | Up to use in co-cultures | ||
Goranci-Buzhala et al[23] | Guided | EB formation/neural induction | ULA 96-well | NIM | - | ROCKi | - | 5 days |
ECM embedding | NR | Neurobasal + DMEM/F12 | N2s, B27s without vitamin A, 2-ME, human insulin, L-glutamin, MEM-NEAA | - | Matrigel | 4 days | ||
Neural differentiation/maturation | Spinner flask | Neurobasal + DMEM/F12 | N2s, B27s without vitamin A, 2-ME, human insulin, L-glutamin, MEM-NEAA | DM and SB-431542 | - | Up to use in co-cultures (> 10 days) | ||
Linkous et al[24] | Unguided | EB formation/neural induction | LA 96-well | NIM | - | ROCKi | - | 6-7 days |
Rosettes formation | Matrigel-coated 6-well | NIM | - | - | - | 11-14 days | ||
ECM embedding | NR | Neurobasal + DMEM/F12 | N2s, B27s without vitamin A, 2-ME, human insulin, Glutamax, MEM-NEAA | - | Matrigel | 4 days | ||
Neural differentiation/maturation | Spinning bioreactor or orbital shaker | Neurobasal + DMEM/F12 | N2s, B27s with vitamin A, 2-ME, human insulin, Glutamax and, MEM-NEAA | - | - | Up to use in co-cultures (> 25 days) |
- Citation: Alves ADH, Ennes do Valle NM, Yokota-Moreno BY, Galanciak MCDS, Felix da Silva K, Mamani JB, Sertie AL, de Oliveira FA, Nucci MP, Gamarra LF. Stem cell-derived neural organoids as platforms to investigate glioblastoma invasion and migration: A systematic review. World J Stem Cells 2025; 17(8): 108898
- URL: https://www.wjgnet.com/1948-0210/full/v17/i8/108898.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i8.108898